Halley E. Gilbert
Insider Reports History
- Location
- San Carlos, CA
- Signature
- /s/Latha Vairavan, as Attorney-in-Fact for Halley E. Gilbert
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Halley E. Gilbert:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NEOGENOMICS INC | Chief Legal Officer | Common Stock | 147,396 | $2,710,612 | $18.39 | 01 Mar 2022 | Direct |
| Arcutis Biotherapeutics, Inc. | Director | Common Stock | 22,123 | $609,468 | $27.55 | 20 Nov 2025 | Direct |
| Vaxcyte, Inc. | Director | Stock Option (right to buy) | 15,372 | $445,788 | $29.00 | 12 Jun 2025 | Direct |
| Vaxcyte, Inc. | Director | Common Stock | 10,216 | $296,264 | $29.00 | 12 Jun 2025 | Direct |
| NEOGENOMICS INC | Chief Legal Officer | Stock Option (Right to Buy) | 102,623 | 01 Mar 2022 | Direct | ||
| CytomX Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 38,000 | 11 Jun 2025 | Direct | ||
| Arcutis Biotherapeutics, Inc. | Director | Stock Option (right to buy) | 0 | 20 Nov 2025 | Direct |
Insider Reports Filed by Halley E. Gilbert
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ARQT | Arcutis Biotherapeutics, Inc. | 20 Nov 2025 | 3 | -$363,670 | 4 | Director | 21 Nov 2025, 18:21 |
| ARQT | Arcutis Biotherapeutics, Inc. | 12 Jun 2025 | 2 | $0 | 4 | Director | 16 Jun 2025, 20:17 |
| PCVX | Vaxcyte, Inc. | 12 Jun 2025 | 2 | $0 | 4 | Director | 16 Jun 2025, 18:10 |
| CTMX | CytomX Therapeutics, Inc. | 11 Jun 2025 | 1 | $0 | 4 | Director | 13 Jun 2025, 16:16 |
| ARQT | Arcutis Biotherapeutics, Inc. | 14 Jun 2024 | 2 | $0 | 4 | Director | 18 Jun 2024, 16:51 |
| PCVX | Vaxcyte, Inc. | 06 Jun 2024 | 2 | $0 | 4 | Director | 10 Jun 2024, 16:10 |
| PCVX | Vaxcyte, Inc. | 03 Jun 2024 | 3 | -$1,231,230 | 4 | Director | 05 Jun 2024, 16:59 |
| CTMX | CytomX Therapeutics, Inc. | 15 May 2024 | 1 | $0 | 4 | Director | 17 May 2024, 17:32 |
| CTMX | CytomX Therapeutics, Inc. | 14 Jun 2023 | 1 | $0 | 4 | Director | 16 Jun 2023, 17:49 |
| PCVX | Vaxcyte, Inc. | 13 Jun 2023 | 2 | $0 | 4 | Director | 15 Jun 2023, 17:52 |
| ARQT | Arcutis Biotherapeutics, Inc. | 31 May 2023 | 2 | $0 | 4 | Director | 02 Jun 2023, 19:08 |
| CTMX | CytomX Therapeutics, Inc. | 15 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 16:06 |
| ARQT | Arcutis Biotherapeutics, Inc. | 01 Jun 2022 | 2 | $0 | 4 | Director | 03 Jun 2022, 16:56 |
| PCVX | Vaxcyte, Inc. | 01 Jun 2022 | 2 | $0 | 4 | Director | 03 Jun 2022, 16:29 |
| NEO | NEOGENOMICS INC | 01 Mar 2022 | 2 | $0 | 4 | Chief Legal Officer | 03 Mar 2022, 18:59 |
| NEO | NEOGENOMICS INC | 31 Dec 2021 | 1 | +$5,540 | 5 | Chief Legal Officer | 08 Feb 2022, 18:12 |
| NEO | NEOGENOMICS INC | 30 Dec 2021 | 1 | $0 | 4 | Chief Legal Officer | 30 Dec 2021, 17:02 |
| NEO | NEOGENOMICS INC | 17 Aug 2021 | 2 | $0 | 4 | Chief Legal Officer | 19 Aug 2021, 17:42 |
| NEO | NEOGENOMICS INC | 17 Aug 2021 | 0 | $0 | 3 | Chief Legal Officer | 19 Aug 2021, 17:41 |
| CTMX | CytomX Therapeutics, Inc. | 16 Jun 2021 | 1 | $0 | 4 | Director | 17 Jun 2021, 18:43 |
| ARQT | Arcutis Biotherapeutics, Inc. | 09 Jun 2021 | 1 | $0 | 4 | Director | 11 Jun 2021, 16:36 |
| PCVX | Vaxcyte, Inc. | 02 Jun 2021 | 1 | $0 | 4 | Director | 03 Jun 2021, 18:46 |